Interrupting and Resuming GLP-1 Therapy for Weight Loss May Reduce Drug Effectiveness
In recent years, GLP-1 receptor agonists such as semaglutide (marketed under brand names like Ozempic and Wegovy) have revolutionized the pharmacological landscape for weight management....
















